Doxorubicin acts via mitochondrial ROS to stimulate catabolism in C2C12 myotubes. 2012

Laura A A Gilliam, and Jennifer S Moylan, and Elaine W Patterson, and Jeffrey D Smith, and Anne S Wilson, and Zaheen Rabbani, and Michael B Reid
Department of Physiology, University of Kentucky, Lexington, Kentucky 40536-0298, USA.

Doxorubicin, a commonly prescribed chemotherapeutic agent, causes skeletal muscle wasting in cancer patients undergoing treatment and increases mitochondrial reactive oxygen species (ROS) production. ROS stimulate protein degradation in muscle by activating proteolytic systems that include caspase-3 and the ubiquitin-proteasome pathway. We hypothesized that doxorubicin causes skeletal muscle catabolism through ROS, causing upregulation of E3 ubiquitin ligases and caspase-3. We tested this hypothesis by exposing differentiated C2C12 myotubes to doxorubicin (0.2 μM). Doxorubicin decreased myotube width 48 h following exposure, along with a 40-50% reduction in myosin and sarcomeric actin. Cytosolic oxidant activity was elevated in myotubes 2 h following doxorubicin exposure. This increase in oxidants was followed by an increase in the E3 ubiquitin ligase atrogin-1/muscle atrophy F-box (MAFbx) and caspase-3. Treating myotubes with SS31 (opposes mitochondrial ROS) inhibited expression of ROS-sensitive atrogin-1/MAFbx and protected against doxorubicin-stimulated catabolism. These findings suggest doxorubicin acts via mitochondrial ROS to stimulate myotube atrophy.

UI MeSH Term Description Entries
D008660 Metabolism The chemical reactions in living organisms by which energy is provided for vital processes and activities and new material is assimilated. Anabolism,Catabolism,Metabolic Concepts,Metabolic Phenomena,Metabolic Processes,Metabolic Phenomenon,Metabolic Process,Metabolism Concepts,Metabolism Phenomena,Process, Metabolic,Processes, Metabolic,Concept, Metabolic,Concept, Metabolism,Concepts, Metabolic,Concepts, Metabolism,Metabolic Concept,Metabolism Concept,Phenomena, Metabolic,Phenomena, Metabolism,Phenomenon, Metabolic
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017382 Reactive Oxygen Species Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS. Active Oxygen Species,Oxygen Radical,Oxygen Radicals,Pro-Oxidant,Reactive Oxygen Intermediates,Active Oxygen,Oxygen Species, Reactive,Pro-Oxidants,Oxygen, Active,Pro Oxidant,Pro Oxidants,Radical, Oxygen
D018485 Muscle Fibers, Skeletal Large, multinucleate single cells, either cylindrical or prismatic in shape, that form the basic unit of SKELETAL MUSCLE. They consist of MYOFIBRILS enclosed within and attached to the SARCOLEMMA. They are derived from the fusion of skeletal myoblasts (MYOBLASTS, SKELETAL) into a syncytium, followed by differentiation. Myocytes, Skeletal,Myotubes,Skeletal Myocytes,Skeletal Muscle Fibers,Fiber, Skeletal Muscle,Fibers, Skeletal Muscle,Muscle Fiber, Skeletal,Myocyte, Skeletal,Myotube,Skeletal Muscle Fiber,Skeletal Myocyte

Related Publications

Laura A A Gilliam, and Jennifer S Moylan, and Elaine W Patterson, and Jeffrey D Smith, and Anne S Wilson, and Zaheen Rabbani, and Michael B Reid
September 2009, American journal of physiology. Cell physiology,
Laura A A Gilliam, and Jennifer S Moylan, and Elaine W Patterson, and Jeffrey D Smith, and Anne S Wilson, and Zaheen Rabbani, and Michael B Reid
February 2001, The Journal of biological chemistry,
Laura A A Gilliam, and Jennifer S Moylan, and Elaine W Patterson, and Jeffrey D Smith, and Anne S Wilson, and Zaheen Rabbani, and Michael B Reid
February 2021, Antioxidants (Basel, Switzerland),
Laura A A Gilliam, and Jennifer S Moylan, and Elaine W Patterson, and Jeffrey D Smith, and Anne S Wilson, and Zaheen Rabbani, and Michael B Reid
February 2012, Journal of applied physiology (Bethesda, Md. : 1985),
Laura A A Gilliam, and Jennifer S Moylan, and Elaine W Patterson, and Jeffrey D Smith, and Anne S Wilson, and Zaheen Rabbani, and Michael B Reid
May 2014, Biochemical and biophysical research communications,
Laura A A Gilliam, and Jennifer S Moylan, and Elaine W Patterson, and Jeffrey D Smith, and Anne S Wilson, and Zaheen Rabbani, and Michael B Reid
January 2017, Oxidative medicine and cellular longevity,
Laura A A Gilliam, and Jennifer S Moylan, and Elaine W Patterson, and Jeffrey D Smith, and Anne S Wilson, and Zaheen Rabbani, and Michael B Reid
May 2023, Toxicology,
Laura A A Gilliam, and Jennifer S Moylan, and Elaine W Patterson, and Jeffrey D Smith, and Anne S Wilson, and Zaheen Rabbani, and Michael B Reid
January 2014, Journal of nutrition and metabolism,
Laura A A Gilliam, and Jennifer S Moylan, and Elaine W Patterson, and Jeffrey D Smith, and Anne S Wilson, and Zaheen Rabbani, and Michael B Reid
April 2024, Biochimie,
Laura A A Gilliam, and Jennifer S Moylan, and Elaine W Patterson, and Jeffrey D Smith, and Anne S Wilson, and Zaheen Rabbani, and Michael B Reid
January 2019, Frontiers in pharmacology,
Copied contents to your clipboard!